Interleukin-4 (IL-4)-induced T helper (Th) 2 cells promote susceptibility to the protozoan parasite Leishmania major, while conferring immunity to the intestinal trematode Schistosoma mansoni. Here, we report that abrogation of IL-4 receptor alpha (IL-4Rα) signaling on B cells in BALB/c mice (mb1 cre IL-4Rα -/lox ) transformed nonhealer BALB/c to a healer phenotype with an early type 1 and dramatically reduced type 2 immune response and an absence of ulceration and necrosis during cutaneous leishmaniasis. From adoptive reconstitution and mixed bone-marrow chimera studies in B cell-deficient (μMT) mice, we reveal a central role for B cellderived IL-4 and IL-4Rα in the optimal induction of the susceptible type 2 phenotype to L. major infection. We further demonstrate that the absence of IL-4Rα signaling on B cells exacerbated S. mansoniinduced mortality and pathology in BALB/c mice, due to a diminished type 2 immune response. In both disease models, IL-4Rα-responsive B cells displayed increased IL-4 production as early as day 1 after infection. Together, these results demonstrate that IL-4-producing and IL-4Rα-responsive B cells are critical in regulating and assisting early T helper dichotomy toward Th2 responses, which are detrimental in cutaneous leishmaniasis but beneficial in acute schistosomiasis.
Interleukin-4 (IL-4)-induced T helper (Th) 2 cells promote susceptibility to the protozoan parasite Leishmania major, while conferring immunity to the intestinal trematode Schistosoma mansoni. Here, we report that abrogation of IL-4 receptor alpha (IL-4Rα) signaling on B cells in BALB/c mice (mb1 cre IL-4Rα -/lox ) transformed nonhealer BALB/c to a healer phenotype with an early type 1 and dramatically reduced type 2 immune response and an absence of ulceration and necrosis during cutaneous leishmaniasis. From adoptive reconstitution and mixed bone-marrow chimera studies in B cell-deficient (μMT) mice, we reveal a central role for B cellderived IL-4 and IL-4Rα in the optimal induction of the susceptible type 2 phenotype to L. major infection. We further demonstrate that the absence of IL-4Rα signaling on B cells exacerbated S. mansoniinduced mortality and pathology in BALB/c mice, due to a diminished type 2 immune response. In both disease models, IL-4Rα-responsive B cells displayed increased IL-4 production as early as day 1 after infection. Together, these results demonstrate that IL-4-producing and IL-4Rα-responsive B cells are critical in regulating and assisting early T helper dichotomy toward Th2 responses, which are detrimental in cutaneous leishmaniasis but beneficial in acute schistosomiasis.
IL-4R alpha | B cells | leishmaniasis | schistosomiasis | mouse B cells are well known for their ability to differentiate into antibody-secreting plasma cells in response to foreign antigens or pathogens (1) . However, recent studies suggest that B cells appear to regulate both protective and pathologic immune responses by antibody-independent mechanisms. These mechanisms range from the organization of secondary lymphoid tissues and lymphangiogenesis to recognition of antigenic ligands by Toll-like receptors (1, 2) . Activated B cells are also excellent antigen-presenting cells (APCs) capable of internalizing antigen through the B cell receptor (BCR), processing, and presenting peptides to CD4 + T cells in an MHCII-independent manner (1-5). In fact, growing evidence suggests that antigen-presenting B cells assist in regulating the quality and quantity of both primary and memory CD4
+ T helper (Th) cell responses (2, (5) (6) (7) . Besides antibody production and antigen presentation, B cells also influence host immunity by producing cytokines (1, 2, 8) . However, the importance of cytokine-producing B cells in health and disease remained an unexplored aspect until the last decade. Resurgence in this field of B cell biology has led to the subdivision of B cells into distinct cytokine-producing "regulatory" or "effector" subsets, detected both in vivo and in vitro. Regulatory B cells (Bregs) produce IL-10 and TGF-β and are critical in protection against allergic airway inflammation (9), colitis (10) , and collagen-induced arthritis (11) . On the other hand, defined effector B cell subsets produce cytokines such as IFN-γ, IL-12p40, TNF-α or IL-2, IL-6, IL-4, and IL-13 (8, 12, 13) . These B cell-derived cytokines have been described to influence the outcome of infectious diseases. IFN-γ-and IL-12p40-producing B cells have been detected in vivo during infection with a type 1 polarizing parasite Toxoplasma gondii (8, 12) , while infection with the type 2 polarizing parasite Heligmosomoides polygyrus has been shown to induce differentiation of IL-4-and IL-2-producing B cells in vivo (2, 8, 13) . Altogether, these observations demonstrate that B cells produce cytokines in response to foreign antigens or pathogens that might function to initiate and/or maintain the magnitude and quality of CD4 + Th cell-dependent immune responses toward Th1 or Th2 phenotypes. The exact role of cytokine-producing B cells in vivo during cutaneous leishmaniasis, a type 1-controlled disease caused by Leishmania major, and acute schistosomiasis, a type 2-controlled disease caused by Schistosoma mansoni, is not yet established.
Most studies on the contribution of B cells to host defense or susceptibility to L. major or S. mansoni infection have been conducted in BALB/c mice that lack mature B cells due to disruption of the IgM transmembrane domain (μMT). B celldeficient μMT mice were found to be intermediately resistant to L. major infection (14) but developed exacerbated egg pathology and increased mortality in response to S. mansoni infection (15, 16) . However, deletion of the complete B cell population provides very little information on the specific contribution of B cell subsets and derived cytokines to disease outcome. We therefore used a newly generated BALB/c mouse lacking IL-4Rα expression specifically on B cells, mb1
cre IL-4Rα -/lox BALB/c mice (17) , to investigate the role of IL-4Rα-responsive B cells during parasitic
Significance
Cutaneous leishmaniasis and schistosomiasis are neglected tropical diseases for which there are no effective vaccines and limited treatment strategies. To develop vaccine and therapeutic alternatives, a detailed understanding of host immunity is essential. We show a role for IL-4Rα-responsive B cells in host susceptibility to Leishmania major and protection against Schistosoma mansoni infection through the production of early IL-4, which in turn regulates Th2 cell polarization and disease outcome in mice. These important findings highlight the significant impacts that B cell-specific IL-4Rα and IL-4 responsiveness have in the context of type 1 (L. major) and type 2 (S. mansoni) pathogens. Thus, vaccine and therapeutic development should aim to target both B and T cell immunity for optimal efficacy.
infection. The IL-4Rα chain is a common receptor of both the type I (IL-4) and type II (IL-4/IL-13) receptor complexes. Both these cytokines have pleiotropic immune functions, being shown to be responsible for intracellular parasitism caused by L. major (18) (19) (20) (21) and mediating protection to S. mansoni infection (22) (23) (24) .
Using this model, we show that while IL-4Rα-unresponsive B cells are beneficial in cutaneous leishmaniasis, leading to host protective immunity in mb1 cre IL-4Rα -/lox BALB/c mice, these cells are detrimental in acute schistosomiasis, leading to increased host pathology. We further demonstrate that IL-4Rα-deficient B cells differentially regulate mRNA cytokine expression, consistent with Th1 cell dichotomy, as early as day 1 after infection. Importantly, we show that IL-4-producing B cells are critical in driving the susceptible type 2 immune response to cutaneous leishmaniasis in BALB/c mice. Together, these data demonstrate that early IL-4Rα-responsive B cells producing IL-4 influence early Th polarization toward detrimental Th2 responses that drive L. major-induced cutaneous leishmaniasis and protect the host against S. mansoni-induced pathology.
Results
B Cell-Specific IL-4Rα-Deficient BALB/c Mice Are Protected from Cutaneous Leishmaniasis. In a loss-of-function approach, we recently generated B cell-specific IL-4Rα-deficient BALB/c mice (mb1 cre IL-4Rα -/lox ) (17) to investigate a possible role for IL-4-responsive B cells in type 1-controlled cutaneous leishmaniasis. mb1
cre IL-4Rα -/lox , hemizygous littermate control IL-4Rα
BALB/c (expressing functional IL-4Rα), and C57BL/6 mice were infected s.c. with 2 × 10 6 stationary phase metacyclic promastigotes of L. major LV39 strain (MRHO/SV/59/P) into the hind footpad. As expected following L. major infection ( Fig. 1 A and  B) , littermate IL-4Rα -/lox BALB/c mice developed rapidly growing necrotic lesions (N12/14), leading to fulminant cutaneous leishmaniasis within 8 wk of infection, similar to WT BALB/c (IL-4Rα +/+ mice) (21, 25, 26) , whereas the healer C57BL/6 strain controlled tissue pathology without development of necrosis (N0/14) and ulceration (19, 21, 25, 26 
IL-4Rα
-/lox BALB/c mice with strikingly reduced swelling and reduced parasite burden in the footpad (Fig. S1 A and B), analyzed 6 wk postinfection. As expected, global IL-4Rα −/− knockout mice controlled both LV39 and IL81 infection in the footpad in the acute phase (Fig. S1C ) in line with previous reports (21, 25) . Challenging with soluble L. major antigen (SLA) in 6 wk-infected mb1 cre IL-4Rα -/lox BALB/c mice resulted in increased delayed-type hypersensitivity (DTH) (Fig. 1C) , implying heightened memory responses to L. major infection, as known for the healer C57BL/6 strain. Indeed, acute resistance translated to chronic disease control, as demonstrated by the absence of footpad swelling, similar to the C57BL/6 healer strain (Fig. S1D) . Cre-mediated IL-4Rα deletion on B cells was also efficient during infection with impaired IL-4Rα expression only on B cells (Fig. S1E) . In summary, these data suggest a direct role for IL-4Rα-responsive B cells in host susceptibility to cutaneous leishmaniasis. In the absence of B cells during acute LV39 infection, B cell-deficient mice (μMT BALB/c) were moderately susceptible, showing slightly ameliorated footpad swelling and pathogen burden ( Fig. 1 D and E) . However, fulminant cutaneous leishmaniasis arose in μMT mice, whereas mb1 cre IL-4Rα -/lox BALB/c mice mounted a protective immune response altogether, supporting a beneficial role for IL-4Rα-unresponsive B cells during cutaneous leishmaniasis. (Fig. S2 A and B) and a concomitant increase in IFN-γ secretion (Fig. S2C) . This was relatively due to a striking 7-100-fold decrease in Th2 cells secreting IL-4, IL-13, and IL-10, as demonstrated by FACS-sorted LN CD4 + Th cells from infected mb1
cre IL-4Rα -/lox BALB/c mice, restimulated with L. major antigen in the presence of fixed APCs (Fig. 2 A-C) . CD4 + Th1 cells from infected mb1 cre IL-4Rα -/lox BALB/c mice secreted twofold more IFN-γ compared with littermate control mice (Fig. 2D) -/lox BALB/c mice produced significantly more IL12p40/70 and nitric oxide synthase 2 (NOS2), the latter responsible for nitric oxide (NO) production to kill intracellular Leishmania (27), compared with control IL-4Rα -/lox BALB/c mice, measured by flow cytometry ( 
-/lox BALB/c at 8 wk postinfection was not due to differences in IFN-γ levels on B cells, but rather by their ability to down-regulate the type 2 B cellderived cytokine response. 
CD3
− B cells from the dLN and isolated by FACS sorting (>99% purity). Following mRNA extraction, the expression of il-4, il-10, and ifn-γ transcripts were quantified by real-time PCR in comparison with the housekeeping gene hprt. Whereas before infection (day 0) negligible cytokine expression was detected in B cells, B cell-derived il-4 and il-10 was induced in the nonhealer BALB/c mice at day 1 and day 2 and barely induced in mb1
-/lox and C57BL/6 mice ( Fig. 3 E and F ). In contrast, ifn-γ was induced in B cells from resistant mb1
BALB/c mice and to a lesser extent in B cells from nonhealer BALB/c mice, starting at day 1 and gradually declining over the next 3 d (Fig. 3G) . While the absence of B cells does not confer protection against L. major infection (Fig. 1 D and E) , the results above suggest that antigen-primed, cytokine-producing B cells could modulate the immune response to infection in normal mice. We therefore hypothesized that early IL-4Rα-responsive and IL-4-competent B cells could directly confer susceptibility to L. major infection by directing Th cells toward predominant Th2 responses. To investigate this, we adoptively transferred 1 × 10 6 B cells (B220 /IL-4Rα −/− BALB/c animals contained acute infection (Fig. S7 A and B) . Accordingly, transfer of L. majorprimed IL-4Rα-responsive B cells from susceptible BALB/c mice augmented acute cutaneous leishmaniasis by week 6 postinfection, demonstrated by increasing footpad swelling (Fig. 3H ) and increased parasite loads (Fig. 3I ) in μMT mice (μMT-BALB/c B cells). In contrast, L. major-primed B cells deficient for the IL-4Rα chain, competent in IL-4 production but unable to respond to IL-4 (μMT-IL-4Rα −/− B cells), partially reduced footpad swelling and parasite loads in naïve μMT recipients ( −/− B cells) showed control of disease with significant reduced footpad swelling by week 6 postinfection and reduced parasite load (Fig. 3 H and I) . We observed that disease progression was slightly delayed following adoptive transfer of antigen-primed B cells into μMT mice, which has been previously documented (14) . However, footpad pathology, in terms of ulceration and necrosis, was completely absent in μMT mice reconstituted with IL-4/IL-4Rα −/− B cells (N 0/12 ), confirming control of disease in these animals. In contrast, the high -/lox BALB/c control mice as significant (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P < 0.0001).
degree of ulceration and necrosis as seen in μMT mice reconstituted with WT BALB/c B cells (N 8/11 ) indicates exacerbated disease as a consequence of exaggerated immunopathology, tissue destruction, apoptosis, and parasite replication. Disease control in μMT animals reconstituted with IL-4
−/− BALB/c B cells could be further explained by increased IFN-γ and reduced IL-4 and IL-13 production in LN cells when restimulated with α-CD3 (Fig. S7 C-E) . The reduction of IL-4 was further reflected in a dominant type 1 antibody response and reduced type 2 (Fig.  S7 F and G) . These results confirm our previous observations that IL-4Rα-responsive B cells contribute to host susceptibility to L. major (Fig. 1) and further suggest that IL-4 produced by B cells is responsible for promoting disease progression.
We further strengthened this conclusion by generating mixed bone-marrow (BM) chimeras as reported (2) chimeras were created (Fig. S8) . At 8 wk postinjection, we confirmed successful reconstitution in all chimeric groups, demonstrated by similar cell number and cell-type distribution (Fig. S9) . Importantly, apart from μMT animals, all chimeric groups maintained equivalent repopulation of CD19 + B220 + B cells (Fig. S9B ). Mice were infected with 2 × 10 6 promastigotes of L. major LV39 strain for 8 wk. As anticipated, control 100% BL/6 chimeras healed and 100% IL-4 −/− chimeras contained acute leishmaniasis with low footpad swelling, the absence of acute cutaneous leishmaniasis, demonstrated by the absence of necrosis and ulceration, as well as lowered footpad (1.6-fold) and LN burden (Fig. 4 A-C) . As expected, this was due to a beneficial dominant type 1 immune response (Figs. 4 D and E and 5 A-F), as previously shown by us in IL-4-deficient BALB/c mice (18) . In stark contrast, μMT B-WT chimeras developed typical acute cutaneous leishmaniasis followed by μMT chimeras (Fig. 4 A-C) due to detrimental type 2 responses (Figs. 4 D and E and 5 A-F). Confirming the adoptive transfer results (Fig. 3 H-J) , μMT mice reconstituted with IL-4-impaired B cells (B-IL-4 −/− chimeras) efficiently controlled cutaneous leishmaniasis (only 1 of 14 mice developed ulceration on lesions), with reduced pathogen burden in the footpad (1.5-fold) followed by the dLN (1.2-fold) compared with B-WT animals (Fig. 4 A-C) . We observed that parasite replication in the footpad of B-IL-4 −/− and IL-4 −/− chimeras was controlled to a greater degree than in the LN compared with μMT B-WT chimeras. The footpad has a higher frequency of iNOS-secreting macrophages and DCs to host parasites than the LN and is capable of killing intracellular parasites (25, 27) , which might account for a slower but effective control in the LN. This was further accompanied by strikingly reduced detrimental type 2 antibody (Fig. 4 D and E) and Th2 immune responses (Fig. 5 A-C) and up-regulated IFN-γ responses (Fig. 5D ), leading to efficient NO killing effector responses ( Fig. 5I and Fig. S3B ). The absence of IL-4 on B cells and IL-4 globally in B-IL-4 −/− and 100% IL-4 −/− chimeras was further confirmed by quantitative RT-PCR on B cells FACSsorted from the dLN of chimeric mice at 8 wk after infection (Fig. 5E) . B cell-derived IL-13 was also reduced in the absence of IL-4 on B cells and IL-4 globally (Fig. 5F) . Surprisingly, levels of B cell-derived IL-10 remained unaltered (Fig. 5G) , while B cellderived IFN-γ (Fig. 5H ) marginally increased. Together, these data demonstrate that early IL-4Rα-responsive B cells producing IL-4 influence early Th cell polarization toward detrimental Th2 responses, which leads to L. major-induced cutaneous leishmaniasis.
S. mansoni Eggs Induce Early IL-4 in B Cells. The question remained if B cell regulation of T cell dichotomy is rather an exception of this specific disease or a more general mechanism. To directly test this in a time-controlled manner, we injected 2,500 S. mansoni eggs into the hind footpad of animals to elicit a robust and swift type 2 immune response, as previously described (30, 31) . Subsequently, we sorted for B220
− B cells by flow cytometry at day 0, 2, and 4 post-egg challenge, extracted mRNA, and quantified cytokine transcripts by qRT-PCR. Similar to the findings obtained from L. major-infected B cells (Fig. 3G) , IL-4Rα-responsive B cells induced higher il-4 transcripts at day 4 post-egg challenge than B cells impaired of IL-4Rα signaling (mb1 cre IL-4Rα -/lox and IL-4Rα −/− mice) (Fig. 6A) . We detected transcripts for il-10, il-6, and tnf-α, although they were not differentially expressed between the different strains ( Fig. 6 B-D) . Interestingly, we found that tnf-α transcripts were highly expressed by B cells from IL-4Rα −/− mice at day 0 but were significantly reduced after egg challenge similarly to IL-4Rα -/lox littermate control mice and mb1 cre IL-4Rα -/lox mice (Fig. 6D) . Conclusively, the absence of IL-4Rα-responsive B cells reduces early IL-4 transcripts following exposure to S. mansoni eggs. 
IL-4Rα
-/lox mice with S. mansoni may be detrimental to the host, contrary to our findings in L. major infection studies. Indeed, we found that mb1 cre
-/lox mice infected with S. mansoni quickly succumbed to infection similarly to the highly susceptible IL-4Rα −/− mice compared with infected IL-4Rα -/lox littermate control mice that died significantly later (Fig.  7A ) without weight loss (Fig. 7B) . S. mansoni-infected mb1
-/lox mice presented with exacerbated liver pathology indicated by augmented granuloma formation (Fig. 7C ) and increased hepatocellular damage shown by increased serum aspartate transaminase concentration (Fig. 7D) (Fig. 7 F and G) . This was further confirmed by reduced type 2 antibody titres (IgG1 and total IgE) but increased type 1 antibody titres (IgG2a) compared with IL-4Rα -/lox littermate control mice (Fig. 7 H and I) . Together, these results suggest that early IL-4Rα-responsive and IL-4-producing B cells are crucial for driving an efficient Th2 and Type 2 immune response necessary to confer protection against acute schistosomiasis.
Discussion
The introduction of gene-deficient mouse models for IL-4Rα and its ligands, IL-4 and IL-13, challenged the basic premise that the IL-4/IL-13/IL-4Rα axis acted in isolation to regulate host susceptibility to the type 1 disease cutaneous leishmaniasis, caused by L. major (20) , or host protection to the type 2 disease schistosomiasis, caused by S. mansoni (32) . This led to paradigm shifts in the literature and suggested that both IL-4/IL-13-dependent and IL-4/IL-13-independent factors orchestrate disease outcome. Leading on from these investigations and others, crucial roles for alternate cytokines, Th cell lineages, and immune cell populations were revealed. In this study, we report on the contribution of IL-4-responsive B cell responses to acute cutaneous leishmaniasis and schistosomiasis in mice.
B lymphocytes are believed to play only a limited role in Th2-mediated susceptibility to Leishmania infection (14, 33, 34) and resistance to S. mansoni infection (15, 16) , as the absence of B cells in B cell-deficient mice do not critically alter host ability to control either infection. This is not surprising given that BALB/c mice have a default Th2 pathway that is still activated upon Leishmania infection even in the absence of B cells (35) . However, this conclusion changed substantially when we disrupted IL-4Rα expression on B cells in mb1 cre IL-4Rα -/lox BALB/c mice in experimental cutaneous leishmaniasis and acute schistosomiasis. As a result, nonhealer BALB/c mice with predominant and detrimental type 2 responses during L. major infection transformed to a healer strain with beneficial type 1 responses due to the absence of IL-4Rα-responsive B cells, bearing a similar phenotype to CD4 + T cell-specific IL-4Rα-deficient BALB/c mice (21) . Of importance, the observed T cell shift was not limited to type 1 diseases, as subsequent infection of B cell-specific IL-4 receptor alpha (IL-4Rα)-deficient mice with S. mansoni resulted in diminished type 2 responses, which was detrimental to the host with early mortality and pathology, as seen before in S. mansoni-infected pan-T cell IL-4Rα-deficient BALB/c mice (22) . Reconstitution studies in μMT B cell-deficient animals demonstrated that nonhealing disease to L. major could be controlled by the removal of IL-4Rα −/− mice) had an added beneficial effect, highlighting that IL-4 + B cells play an essential exacerbatory role in cutaneous leishmaniasis. Indeed, chimeric mouse models confirmed that the selective absence of IL-4-responsive B cells is a key trigger for the generation of host-protective humoral and cellular immune responses to L. major. Thus, our study provides evidence that B cell IL-4 and IL-4Rα is critical in the nonhealing response to L. major.
How might IL-4Rα signaling on B cells and its ligand lead to activation of B cells and release of IL-4 to influence Th dichotomy? Functionally, we demonstrated that the loss of IL-4Rα + B cells in both diseases altered the quality and quantity of cytokines secreted by effector B cells as early as day 1 after infection (Figs. 3 and 6 ), which in turn apparently influenced dendritic cells and early Th cells. This suggests that the early B cell-derived IL-4 could act on the IL-4Rα chain and activate the B cell population to sustain IL-4 production, thereby creating an autocrine loop, while also signaling IL-4Rα-responsive DCs and T cells in a paracrine manner, which together either exacerbate or control disease depending on the disease model. Another source of early IL-4 after L. major infection is attributed to the CD4 + T cells expressing the Vβ4Vα8 T cell receptor that recognizes the Leishmania antigen LACK (Leishmania homolog of receptors for activated C kinase) (36) . Importantly, progressive infection in susceptible strains is attributed to sustained IL-4 production and an inability to redirect this early Th2 response toward a protective Th1 response (18, 20, 25) . Collectively, B cells could become activated by directly responding to antigen, releasing this early IL-4, and in an autocrine loop, enhancing the
This is supported by the fact that B cells with their repertoire of natural antibodies are possibly the first cells of adaptive immunity to recognize and acquire foreign antigen through their BCR, independent of MHCII support. Besides BCR signaling, recent reports indicate that B cells can respond to antigen and become "innately" activated via alternative mechanisms such as activation of endosomal Toll-like receptors or direct peptide loading, which has been shown to lead to early B cell cytokine production, again mimicking an autocrine loop (37) (38) (39) (40) . Furthermore, B cells are competent APCs (4), which would allow the B cells to present the acquired antigen and, together with the cytokine it secretes, facilitate the aforementioned paracrine activation of neighboring immune cells, as previously demonstrated during the early stages of bacterial and viral infection (41) . In contrast, naïve CD4 + T cells are "blind" and completely dependent on MHCII support to recognize foreign antigens presented on APCs through their T cell receptor. Differentiation into Th1 or Th2 cells depends on the cytokines secreted in their vicinity, which then regulates and modulates the disease outcome. Indeed, previous studies have confirmed that early blocking of IFN-γ or IL-4 production shifts Th cell polarization, altering the disease outcome (28, 42) , strengthened by the selective recruitment of either IL-4Rα or the IFN-γ receptor to the immunological synapse in the absence of Th1-and Th2-inducing signals, respectively (43) . Thus, naïve T cell precursors may be able to take advantage of cytokine-producing B cells as differentiation signals (44) , strengthening the possibility that B cells can control and enhance inflammation and Th cell differentiation, not just as bystander cells but as direct participants.
A hallmark in vitro study by Harris et al. (8) first documented the presence of distinct cytokine-secreting B cell subsets. B cells that secreted higher amounts of IFN-γ and IL-12 were termed B effector 1 cells (Be1 cells), while B cells that produced more IL-4, IL-13, IL-10, and IL-2 were named Be2 cells. To date, these subsets of cytokine-producing B cells have been implicated in various mouse models of parasitic and bacterial infection (2, 7, 8, 45, 46) , in models of ulcerative colitis (10) and autoimmunity (11, 47) , and in human infectious and autoimmune diseases (45, 48, 49) . However, with the exception of IL-10 and, recently, type I IFNs (40) , the functional role of B cell-derived cytokines in human leishmaniasis and schistosomiasis have until now not been investigated. The distinct cytokine profiles of IL-4Rα-responsive and IL-4Rα-unresponsive B cells reported here corroborate CD4 + Th1 and Th2 cells, respectively. Indeed, the data from our adoptive B cell transfer experiments highlight that a clear phenotype in B cells is solely capable of altering the outcome of cutaneous leishmaniasis in B cell-deficient animals. Our study therefore supports the idea that the repertoire of early cytokine-producing B cells can regulate CD4 + Th cell dichotomy and together initiate and maintain the immune response elicited in type 1/type 2-controlled diseases.
Of note, the immune response mediated by IL-4-producing B cells tends to be pathogen-specific. While we show a relevance for IL-4-producing B cells in immunity to S. mansoni and susceptibility to L. major, it was previously shown to be dispensable for immunity to H. polygyrus (2) and Nippostrongylus brasiliensis (50) . Indeed, the role of IL-4 itself in cutaneous leishmaniasis has been contentious, being shown to be either important for susceptibility (18, 19) or dispensable for disease progression (51) . These discrepancies have been attributed to strain differences in the source of parasites, parasite dose, and the embryonic stem cells used to generate IL-4 knockout mice. Moreover, apart from a Th2-promoting role, IL-4 has also been reported to instruct DCs to secrete IL-12 for protective Th1 responses to L. major LV39 (25, 52) and shown to instruct protective immunity and successful chemotherapy to L. donovani infection (53) . Altogether, these reports and the work presented here highlight that IL-4 plays a dynamic, multifaceted role in the spectrum of human leishmaniasis, and these differing roles must be considered in targeting this cytokine in a treatment or vaccine.
Importantly, previous work by us reported that IL-4 −/− BALB/c mice are resistant to L. major due to a suppression of the nonhealing IL-4-driven Th2 response and induction of the protective IFN-γ response (18) . Our present study expands on these findings, suggesting that resistance to L. major in IL-4 −/− BALB/c mice may not be solely due to the absence of IL-4-producing T cells but also influenced by the absence of early and late IL-4-producing B cells. A separate study has reported that IL-10-producing B cells influence susceptibility to L. major (54) . In agreement, L. major susceptibility in BALB/c mice was associated with increased B cell IL-10 and IL-4 transcription, whereas control of infection in mb1 cre IL-4Rα -/lox mice correlated with reduced B cell IL-10 mRNA transcripts. This suggested reciprocal roles for IL-4/IL-10 in the nonhealing response to L. major. However, this proved fallacious, as we found no change in IL-10 secretion following removal of IL-4 + B cells. Interestingly, the original paper on Be1 and Be2 cells reported similar IL-10 levels between these two populations (8) . Following on, Wojciechowski et al. (2) also found no role for B cell IL-10 in H. polygyrus infection, and a recent study (55) suggests that T cell IL-10 plays a more crucial role in the nonhealing response to L. major and, in lieu of our data, acts independently of B cell IL-4.
In summary, we report that IL-4Rα signaling on B cells might play an essential role in the nonhealing response to L. major, similar to Th2 cells (21) . We therefore conclude that early B cells modulate pathologic and protective immune responses during type 1-and type 2-controlled diseases by differentially regulating early cytokine production, which in turn influences the effector functions of other cell types, mainly CD4 + Th cells. Thus, vaccine and therapeutic development should aim to target both B and T cell immunity for optimal efficacy. Early B cell-specific IL-4Rα blocking may be a possible therapy for type 1 diseases, as recently demonstrated in IL-4-driven allergy (56) and others (57, 58) , and reciprocally, early IFN-γ/IFN-γ receptor and IL-12 blocking may be beneficial for type 2 diseases. However, further research is required to determine if such a therapy might be applicable for all cutaneous Leishmania given the strain and model specificity reported for IL-4 in this disease.
Materials and Methods

Generation and Genotyping of mb1
cre IL-4Rα -/lox BALB/c Mice. Generation, characterization, and genotyping of mb1 cre IL-4Rα -/lox BALB/c mice are previously described (17) . All mice were housed in specific pathogen-free barriers at the University of Cape Town animal facility. All mouse experiments were approved by the Animal Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town and were conducted in accordance with the recommendations of the South African national guidelines and University of Cape Town practice of laboratory animals.
L. major Infection. L. major LV39 (MRHO/SV/59/P) and L. major IL81 (MHOM/ IL/81/FEBNI) strains were maintained by continuous passage in BALB/c mice and prepared for infection as previously described (19) . Anesthetized mice were inoculated s.c. into the left hind footpad with 2 × 10 6 (LV39) or 2 × 10 5 (IL81) stationary phase metacyclic promastigotes. Footpad swelling was measured weekly using a Mitutoyo caliper (Brütsch).
Detection of Viable Parasite Burden in L. major-Infected Mice. Detection of viable parasite burden from infected footpad and draining LNs was estimated by twofold limiting dilution assay in Schneider's culture medium (Sigma) as previously described (19) .
Live S. mansoni Infection of Mice. Mice were percutaneously infected with 100 live cercariae (acute infection) of a Puerto Rican strain of S. mansoni obtained from infected Biomphalaria glabrata (a gift from Adrian Mountford, University of York, York, UK). The mice were weighed weekly.
Footpad S. mansoni Egg Model. S. mansoni egg challenge was conducted as previously described (30, 31) . Briefly, 2,500 S. mansoni eggs were injected s.c. into the hind footpad, and mice were killed at day 7 postchallenge.
Antibodies and Flow Cytometry. The following antibodies comprising the B cell antibody panel were used: B220, CD19, CD124 (IL-4Rα), CD23, CD21, CD24, and MHCII (BD Bioscience). The T cells panel consisted of the following antibodies: CD4, CD3, CD62L, and CD44 (BD Bioscience). For intracellular cytokine staining, single-cell suspensions were stimulated at 37°C with 50 ng/mL phorbal myristate acetate (PMA), 250 ng/mL ionomycin, and 200 μM monensin in IMDM/10% FCS (all Sigma-Aldrich). Cells were stained with extracellular markers, fixed in 2% (wt/vol) paraformaldehyde, permeabilized with 0.5% saponin buffer, and stained with PE-labeled anti-mouse antibodies and isotype controls (BD Biosciences). iNOS production was analyzed in CD11c hi MHCII hi CD11b + Ly6c hi inflammatory DCs by staining for expression of intracellular iNOS using rabbit anti-mouse iNOS antibody (Abcam) followed by goat anti-rabbit PE (Abcam). Cells were acquired on a FACS Fortessa (BD Immunocytometry), and data were analyzed using Flowjo software (Treestar).
Ex Vivo Restimulation. Single-cell suspensions were stimulated with plate-bound α-CD3 (20 μg/mL) or with 50 μg/mL SLA or 20 μg/mL soluble SEA. Supernatants were collected after 72 h, and cytokines were measured by sandwich ELISA as previously described (19) . Antigen-specific restimulation of CD4 + T cells from infected mice was performed as previously reported (25) .
Cell Sorting. Total LN cells from L. major-and S. mansoni-infected animals were labeled with specific mAbs for B cells (CD19 + B220 + CD3
−
) and isolated by cell sorting on a FACS Vantage machine. Purity was determined by flow cytometry and was at least >98%.
